Off-the-shelf or custom: the billing tier that determines what gets fitted to your body

Medicare pays more for custom clinical work in O&P care. An O&P Edge analysis this week identifies the compliance risk when providers take the easier path—and what patients can ask at their next appointment.

A billing coordinator reviewing a Medicare DMEPOS claim form with a calculator nearby

There is a billing distinction inside the Medicare DMEPOS system that most patients never hear about, but that shapes which device ends up on their body. It is the line between off-the-shelf and custom-fabricated or custom-fitted prosthetics and orthotics. The O&P EDGE published an analysis this week on what happens when providers drift toward the wrong side of that line—and the compliance risk that follows.

What the hierarchy is

The Medicare DMEPOS payment system sorts prosthetics and orthotics into tiers based on the clinical work involved.

An off-the-shelf item is prefabricated: it exists in standard sizes, can be adjusted without significant clinical skill, and is fit directly from inventory. A custom-fabricated device is made for one patient from a mold or measurements, involves substantial clinician time, and usually requires formal prior authorization. A custom-fitted device sits in between—prefabricated, but requiring significant clinical judgment to fit correctly to a specific body.

CMS has reinforced this hierarchy since 2014, linking reimbursement to the level of clinical labor each tier involves. More clinical work, more documentation, higher payment. The logic is to price care at the complexity it actually requires.

Where the path of least resistance appears

The risk The O&P EDGE identifies is not billing fraud in the obvious sense. It is something more routine: providers choosing the tier that requires less paperwork and clinical time when a patient’s situation calls for something more.

An off-the-shelf device is faster to fit, simpler to document, and comes with fewer prior-authorization steps than a custom-fabricated one. For a clinic under scheduling pressure, that difference is real. The compliance problem is that the easier billing path is only appropriate when it is also the clinically appropriate path. When it is not—when the patient’s anatomy, functional goals, or rehabilitation history call for a custom device—the easier bill is a clinical shortcut.

The result for the patient can look like adequate care. They have a device. It functions. But “functions” and “fits correctly for this body and this life” are not the same standard.

What this means at an appointment

You will rarely be told during a fitting that an off-the-shelf device was selected over a custom one, or what the reasoning was. Clinical decision-making of that kind generally lives in the chart.

That is worth knowing because it is information you are entitled to ask for. Some questions worth bringing:

  • What category is this device—off-the-shelf, custom-fitted, or custom-fabricated?
  • What drove that selection over the alternatives?
  • If my needs change or the fit is not working, what would a custom evaluation look like?

For lower-limb prosthetic users: the K-level—Medicare’s functional classification that determines which prosthetic components you can access—is already a documented part of your record. It is reasonable to ask what your assigned K-level is and whether your current device corresponds to what that level typically warrants.

None of this is adversarial. A provider who is doing their job correctly will have clear answers. Difficulty getting a direct answer about the basis for a device selection is itself useful information.

The compliance picture

The O&P EDGE’s analysis frames this as a risk for O&P practices, not patients—audit exposure lands on the provider if documentation does not support the billing tier claimed. But the downstream effect of misaligned billing and clinical decision-making is a patient-side problem: people fitted with devices below the clinical threshold their needs actually require.

DMEPOS billing audits are a recurring feature of the Medicare enforcement landscape. The enrollment moratorium running since February 27—reported here earlier this week—is part of the same effort to keep DMEPOS claims honest. The path-of-least-resistance risk is one reason this category draws sustained auditor attention.

The next useful question

The practical question is not whether your individual provider is cutting corners. Most are not. It is whether the system they operate in gives them the time and reimbursement infrastructure to do the clinical work that a custom device actually requires.

If you have concerns about whether your current device is appropriate for your needs, a second evaluation at a different clinic—with your chart—is a documented and reasonable step. The ABC (American Board for Certification in Orthotics, Prosthetics & Pedorthics) and BOC (Board for Orthotist/Prosthetist Certification) both maintain online directories of credentialed providers.


This article explains Medicare billing policy and how it may affect clinical care. It is not a substitute for evaluation by a credentialed orthotist or prosthetist who can assess your specific situation.

Source notebook: This reporting draws on The O&P EDGE's August 2026 analysis of billing-tier compliance risk in orthotics and prosthetics care ↗. We link out so you can follow the receipts.